About
PharmaEssentia is a Taiwanese biopharmaceutical company that develops interferon-based therapies for chronic blood cancers, specializing in treatments for myeloproliferative neoplasms such as polycythemia vera and essential thrombocythemia.
Explore PharmaEssentia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.